EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations

T A Doelman, N Adriaens, B M Westerhuis, S M Bruisten, C E Vergunst, F M Bouwman, A P van Dam

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkae430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von T A Doelman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Anti-Bacterial Agents, Macrolides, Drug Resistance, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Health Service of Amsterdam.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Mycoplasma genitalium, a sexually transmitted bacterium, faces increasing antibiotic resistance, particularly to azithromycin. However, presence of macrolide resistance-associated mutations (MRAMs) does not evidently implicate azithromycin treatment failure. This study aimed to establish an in vitro co-culture system of M. genitalium isolates and perform phenotypic susceptibility testing for different antibiotics, focusing on azithromycin to evaluate genotypic and phenotypic resistance across MRAMs.

Methods

Urine specimens testing positive for M. genitalium via nucleic acid amplification were co-cultured with Vero cells. Phenotypic susceptibility testing was performed for eight antibiotics. Growth inhibition and MIC of M. genitalium by azithromycin were compared across different MRAMs.

Results

M. genitalium was cultured from 20/40 (50.0%) positive urine samples, with phenotypic susceptibility tested in a subset. MICs ranged as follows: azithromycin (0.008–>32 mg/L), levofloxacin (1–4 mg/L), moxifloxacin (<0.25–1 mg/L), sitafloxacin (<0.032–0.25 mg/L), minocycline (<0.25–1 mg/L), doxycycline (<0.125–2 mg/L), spectinomycin (<2.5–>25 mg/L) and lefamulin (<0.004–0.063 mg/L). Isolates with A2058T demonstrated 24-, 7-, 15- and 12-fold increases in growth inhibition compared with A2058G at azithromycin concentrations of 4, 8, 16 and 32 mg/L, respectively (P < 0.01). MRAMs ranked from low to high impact on MIC range were as follows: wildtype (0.008–0.016), A2058T (8–32), A2059G (≥32) and A2058G (>32).

Conclusions

This study revealed that M. genitalium isolates vary in azithromycin-induced growth inhibition across MRAMs, potentially explaining differences in clinical treatment efficacy. Phenotypic susceptibility testing for other antibiotics demonstrated relatively low MICs. Future studies should incorporate clinical treatment efficacy and symptom severity to optimize treatment for M. genitalium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumAnti-Bacterial AgentsMacrolidesDrug Resistance, BacterialMutationMicrobial Sensitivity TestsHumansMycoplasma InfectionsAnimalsVero CellsChlorocebus aethiopsPhenotypeFemaleMaleAzithromycin

Substanzen

Anti-Bacterial AgentsMacrolidesAzithromycin

Autor:innen und Institutionen

  • Department of Medical Microbiology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Infectious Diseases, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
  • Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands.
  • Department of Dermatology, Noordwest Ziekenhuisgroep location Den Helder, Den Helder, The Netherlands.

Förderung

  • Public Health Service of Amsterdam

Zitieren

APA

Doelman, T. A., Adriaens, N., Westerhuis, B. M., Bruisten, S. M., Vergunst, C. E., Bouwman, F. M., & van Dam, A. P. (2025). Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae430

Vancouver

Doelman TA, Adriaens N, Westerhuis BM, Bruisten SM, Vergunst CE, Bouwman FM, et al. Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkae430

BibTeX
@article{Doelman2025,
  author = {Doelman, T A and Adriaens, N and Westerhuis, B M and Bruisten, S M and Vergunst, C E and Bouwman, F M and van Dam, A P},
  title = {Phenotypic antibiotic resistance of Mycoplasma genitalium and its variation between different macrolide resistance-associated mutations},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkae430}
}
Kostenlos starten →